Valuation: Treace Medical Concepts, Inc.

Market Cap 286M 250M 231M 214M 406M 27.15B 413M 2.77B 1.08B 13.4B 1.07B 1.05B 46.32B P/E 2026 *
-4.9x
P/E 2027 * -5.28x
Enterprise Value 331M 290M 267M 248M 470M 31.43B 477M 3.2B 1.25B 15.51B 1.24B 1.22B 53.61B EV / Sales 2026 *
1.61x
EV / Sales 2027 * 1.69x
Free-Float
74.37%
Yield 2026 *
-
Yield 2027 * -
1 day-4.08%
1 week-0.71%
Current month+5.53%
1 month+18.98%
3 months+200.00%
6 months+41.89%
Current year+71.43%
1 week 4.1
Extreme 4.105
4.7
1 month 3.38
Extreme 3.385
4.78
Current year 1.17
Extreme 1.17
4.78
1 year 1.17
Extreme 1.17
7.78
3 years 1.17
Extreme 1.17
25.22
5 years 1.17
Extreme 1.17
31.76
10 years 1.17
Extreme 1.17
37.17
Manager TitleAgeSince
Chief Executive Officer 54 2013-06-30
Director of Finance/CFO 56 2020-08-31
Compliance Officer 50 2022-09-30
Director TitleAgeSince
Chairman 54 2025-05-19
Director/Board Member 64 2020-11-19
Director/Board Member 68 2020-11-19
Date Insider Type Main position Quantity % Market Cap.
06-10Buy

Chief Executive Officer

9,891 0.0152%
06-09Other

Chief Executive Officer

0 0%
05-31Buy

Chief Executive Officer

50,000 0.0771%
Change 5-day change 1-year change 3-year change Capi.($)
-3.85%-0.71%-31.82%-81.93% 286M
-0.18%+0.47%+28.30%-2.85% 12.52B
-0.73%-3.34%+62.77%+34.91% 6.06B
-2.14%+1.82%+6.16%+12.43% 5.8B
-1.92%-0.59% - - 4.32B
-4.84%-3.17%-36.50%+4.18% 3.84B
-1.74%-0.80%-27.12%-24.91% 3.82B
+1.13%+14.42%+3.11%-56.94% 2.05B
-1.41%+2.77%+26.25%+261.24% 1.87B
+0.94%+0.33%+57.48%-5.96% 1.52B
Average -1.44%+2.82%+9.85%+15.58% 4.21B
Weighted average by Cap. -1.19%+1.23%+17.49%+13.47%

Financials

2026 *2027 *
Net sales 206M 181M 166M 154M 293M 19.58B 297M 1.99B 776M 9.66B 774M 758M 33.39B 222M 194M 179M 166M 315M 21.05B 320M 2.15B 834M 10.39B 833M 815M 35.91B
Net income -58.31M -51.02M -47.02M -43.58M -82.74M -5.53B -84.07M -564M -219M -2.73B -219M -214M -9.44B -54.66M -47.83M -44.08M -40.86M -77.56M -5.19B -78.81M -529M -206M -2.56B -205M -201M -8.85B
Net Debt 45.05M 39.43M 36.33M 33.68M 63.93M 4.28B 64.96M 436M 169M 2.11B 169M 165M 7.29B 88.04M 77.05M 71.01M 65.81M 125M 8.36B 127M 851M 331M 4.12B 331M 323M 14.25B
Logo Treace Medical Concepts, Inc.
Treace Medical Concepts, Inc. is a medical technology company. It is advancing the standard of care for the surgical management of bunion and related midfoot deformities. It has patented the Lapiplasty 3D Bunion Correction System a combination of instruments, implants, and surgical methods designed to surgically correct all three planes of the bunion deformity and secure the unstable joint, addressing the root cause of the bunion and helping patients get back to their active lifestyles. It has Adductoplasty Midfoot Correction System, designed for reproducible surgical correction of midfoot deformities, the SpeedMTP Rapid Compression Implant for addressing bunions through big toe joint fusions, and two systems for minimally invasive osteotomy surgeries: the Nanoplasty 3D Minimally Invasive Bunion Correction System and the Percuplasty Percutaneous 3D Bunion Correction System. It sells its products to physicians, surgeons, ambulatory surgery centers, hospitals, and stocking distributors.
Employees
450
Date Price Change Volume
26-07-08 US$4.205 -4.65% 127,837
26-07-07 US$4.410 -3.29% 624,865
26-07-06 US$4.560 +8.31% 662,392
26-07-02 US$4.210 -0.47% 460,661
26-07-01 US$4.230 +6.28% 493,356
Trader
Investor
-
Global
-
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
4.410USD
Average target price
4.000USD
Spread / Average Target
-9.30%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. TMCI Stock